Espada Dermatology has purchased the GlyDerm line of skin care products from Lautus Pharmaceuticals. Espada is a wholly-owned subsidiary of Mission Pharmacal and adds breadth to Mission’s established line of dermatological drug products. Prior to this acquisition, Mission offered prescription dermatological products solely through Mission Dermatology and the Brava Pharma Sales Group. The products these two respective units offer will remain in place and are used to relieve dry, itchy sk...